Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa

Danielle E Madden1,2, Timothy Baird1,2,3, Scott C Bell4,5

  • 1Centre for Bioinnovation, University of the Sunshine Coast, Sippy Downs, QLD, Australia.

Genome Medicine
|June 7, 2024
PubMed
Abstract

Insights

Antimicrobial resistance (AMR) in Pseudomonas aeruginosa is a growing concern. A new tool, ARDaP, accurately predicts AMR phenotypes by incorporating chromosomal variants, outperforming existing methods.

Area of Science:

  • Genomics
  • Microbiology
  • Computational Biology

Background:

  • Antimicrobial resistance (AMR) poses a significant global health threat, potentially leading to a post-antibiotic era.
  • Pseudomonas aeruginosa is a key pathogen of concern due to high rates of multi- and pan-drug resistance.
  • Accurate in silico AMR profiling from genomic data is crucial but challenging for P. aeruginosa.

Purpose of the Study:

  • To develop a comprehensive database of P. aeruginosa AMR variants.
  • To identify novel AMR variants through comparative genomics and GWAS.
  • To create and evaluate an improved tool for predicting AMR phenotypes.

Main Methods:

  • Curated a comprehensive database of P. aeruginosa AMR variants.
  • Performed comparative genomics and GWAS on a global isolate dataset (n=1877) with phenotype data.
  • Developed and tested the ARDaP tool against existing AMR prediction software using global and validation datasets.

Main Results:

  • The AMR database includes 3639 mobile genes and 728 chromosomal variants, with 75 novel variants identified.
  • ARDaP achieved a balanced accuracy of 85% (Global) and 81% (Validation) for AMR prediction.
  • ARDaP significantly outperformed abritAMR, AMRFinderPlus, and ResFinder, primarily due to the inclusion of chromosomal variants.

Conclusions:

  • ARDaP provides a highly accurate tool for predicting P. aeruginosa AMR phenotypes, surpassing current methods.
  • Routine use of ARDaP can enhance AMR identification for this difficult-to-treat pathogen.
  • Further research is needed to fully understand the P. aeruginosa resistome, especially colistin resistance.